Invesco’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.6K Buy
+138,006
New +$102K ﹤0.01% 3629
2025
Q2
Sell
-12,209
Closed -$6.96K 3874
2025
Q1
$6.96K Sell
12,209
-667
-5% -$658 ﹤0.01% 3761
2024
Q4
$18.4K Buy
12,876
+1,704
+15% +$3.82K ﹤0.01% 3741
2024
Q3
$21.6K Sell
11,172
-676
-6% -$1.91K ﹤0.01% 3740
2024
Q2
$36.7K Sell
11,848
-78
-0.7% -$322 ﹤0.01% 3848
2024
Q1
$62.4K Sell
11,926
-793
-6% -$3.79K ﹤0.01% 3788
2023
Q4
$41.2K Buy
+12,719
New +$27.5K ﹤0.01% 3761
2023
Q3
Sell
-469,753
Closed -$2.76M 3913
2023
Q2
$2.76M Buy
+469,753
New +$2.73M ﹤0.01% 2526

Other funds holding TNYA

Invesco's TNYA Position: Q1 2026 in Review

Invesco opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 138,006 shares worth $95.6K. The stake represents ﹤0.01% of the portfolio and ranks #3629 among its holdings. This is a return to the name: Invesco previously reported a position in TNYA as recently as Q1 2025.

Invesco first reported a position in TNYA in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.76M in Q2 2023. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Invesco held 138,006 shares of Tenaya Therapeutics worth $95.6K as of Q1 2026.
  • Tenaya Therapeutics was a new Invesco position in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3629 holding.
  • Invesco first reported a position in Tenaya Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • Invesco's Tenaya Therapeutics position peaked at $2.76M in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.